Landmark new cancer drug, just approved, to cost $475,000 a year – and analysts say it’s a bargain

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment. That sounds staggering to many patients – but it’s far less for the treatment than…

Please help us defray the costs of providing this free service with your non-tax-deductible contribution in any amount

Most recent 100 posts


Follow this blog

Email address